MYO5A
protein-codingmyosin VA, the group of Myosin heavy chains, class V
Gene summary
This gene is one of three myosin V heavy-chain genes, belonging to the myosin gene superfamily. Myosin V is a class of actin-based motor proteins involved in cytoplasmic vesicle transport and anchorage, spindle-pole alignment and mRNA translocation. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in this gene cause Griscelli syndrome type-1 (GS1) and neuroectodermal melanolysosomal disease, or Elejalde disease. [provided by RefSeq, Sep 2023]
- MYH12
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~221.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0008962
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0008962
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0008962
Submitter: ClinGen
The MYO5A gene is located on chromosome 15 at 15q21.2 and encodes myosin Va, a member of the unconventional myosin family. Myosin Va is a processive molecular motor that is described to be responsible for the actin-dependent transport of different types of organelles. The protein encoded by this gene is abundant in melanocytes and nerve cells. Mutations in MYO5A gene was first reported in relation to autosomal recessive Griscelli syndrome, type 1 (GS1) in 1997 (Pastural et al., PMID: 9207796). GS1 represents hypomelanosis with a primary neurologic deficit and without immunologic impairment. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six unique variants (4 nonsense, 1 frameshift, 1 intragenic deletion) reported in six unrelated probands in five publications (PMID 9207796, Pastural et al., 2000, PMID: 10704277, Menasche et al., 2003, PMID: 12897212, Thomas et al., 2009, PMID: 19318926, Abd Elmaksoud et al. 2020, PMID 32275080). The gene-disease association is supported by myosin Va biochemical function (Wu et al., 1998), MYO5A expression in human skin cells (Lambert et al., 1998, PMID 9826529) and human cerebellum (Souza et al., 2013, PMID 23558932), functional alteration of MYO5A in human epidermal melanocytes (Van Gele et al., 2008, PMID: 18401430), and mouse models that reproduce part of the human phenotype (Provance et al. 1996, PMID 8962090, Takagishi et al. 2006, PMID 1718550). In summary, MYO5A is definitively associated with autosomal recessive Griscelli syndrome type 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 26Jan2021 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0008962
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0012220
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0008962
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYO5A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001382347.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 104 | 4 | 111 | ||
| missense | 1 | 2 | 248 | 14 | 2 | 267 |
| nonsense | 5 | 1 | 4 | 10 | ||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 7 | 9 | |||
| Total | 8 | 4 | 262 | 118 | 6 | 398 |
Highest pathogenic variant AF is 0.0000018586255
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001369276.1 | 42 | MANE Select | |
| Ensembl | ENSP00000382179.4 | 42 | MANE Select | |
| RefSeq | NP_000250.3 | 41 | Standard | |
| RefSeq | NP_001135967.2 | 40 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vesicle-mediated transport
- Membrane Trafficking
- Translocation of GLUT4 to the plasma membrane
Biological Process
- exocytosis
- post-Golgi vesicle-mediated transport
- chemical synaptic transmission
- visual perception
- vesicle-mediated transport
Molecular Function
- microfilament motor activity
- RNA binding
- calcium ion binding
- protein binding
- calmodulin binding
Cellular Component
- ruffle
- photoreceptor outer segment
- cytoplasm
- lysosome
- early endosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000399231
- Coding exons
- 41
- Length
- 221768
- Individuals with no LoFs
- 124765
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 36
- Defined
- 124801
- p
- 0.000144
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.10 | 723 | 998 | 0.724 | 0.0000584 | 12252 |
| Missense (PolyPhen) | 217 | 382.35 | 0.56754 | 4880 | ||
| Synonymous | 1.06 | 331 | 356 | 0.928 | 0.0000188 | 3412 |
| Loss of Function | 7.71 | 23 | 111 | 0.208 | 0.00000662 | 1278 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000065 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00028 | 0.00028 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00016 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Processive actin-based motor that can move in large steps approximating the 36-nm pseudo-repeat of the actin filament. Involved in melanosome transport. Also mediates the transport of vesicles to the plasma membrane. May also be required for some polarization process involved in dendrite formation. {ECO:0000269|PubMed:10448864}.;
- Disease
- DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Elejalde syndrome (ELEJAS) [MIM:256710]: Autosomal recessive condition characterized by skin hypopigmentation, the presence of large clumps of pigment in hair shafts, silvery-gray hair, accumulation of melanosomes in melanocytes and primary neurological abnormalities. Elejalde syndrome may be the same entity as Griscelli syndrome type I. {ECO:0000269|PubMed:12058346}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.388
Intolerance Scores
- LoFtool
- 0.143
- RVIS EVS
- -1.41
- RVIS percentile EVS
- 4.15
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.797
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |